Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial

Author:

Ehrhardt Stephan1,Porsteinsson Anton P.2,Munro Cynthia A.3,Rosenberg Paul B.3,Pollock Bruce G.4,Devanand Davangere P.5,Mintzer Jacobo67,Rajji Tarek K.4,Ismail Zahinoor8910,Schneider Lon S.1112,Baksh Sheriza N.1,Drye Lea T.1,Avramopoulos Dimitri13,Shade David M.1,Lyketsos Constantine G.3,

Affiliation:

1. Department of Epidemiology; Johns Hopkins Bloomberg School of Public Health; Baltimore MD USA

2. Department of Psychiatry; University of Rochester School of Medicine and Dentistry; Rochester NY USA

3. Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Sciences; Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center; Baltimore MD USA

4. Campbell Family Research Institute and Division of Adult Neurodevelopment and Geriatric Psychiatry, CAMH, Department of Psychiatry; University of Toronto; Toronto ON Canada

5. Division of Geriatric Psychiatry; New York State Psychiatric Institute and College of Physicians and Surgeons of Columbia University; New York NY USA

6. Roper St. Francis Research and Innovation Center; Charleston SC USA

7. Medical University of South Carolina, College of Health Professionals and Ralph H Johnson VA Medical Center; Charleston SC USA

8. Department of Psychiatry; Hotchkiss Brain Institute and O'Brien Institute for Public Health, University of Calgary; Calgary AB Canada

9. Department of Clinical Neurosciences; Hotchkiss Brain Institute and O'Brien Institute for Public Health, University of Calgary; Calgary AB Canada

10. Department of Community Health Sciences; Hotchkiss Brain Institute and O'Brien Institute for Public Health, University of Calgary; Calgary AB Canada

11. Departments of Psychiatry and the Behavioral Sciences and Neurology; University of Southern California Keck School of Medicine and the University of Southern California Leonard Davis School of Gerontology; Los Angeles CA USA

12. Department of Neurology; University of Southern California Keck School of Medicine and the University of Southern California Leonard Davis School of Gerontology; Los Angeles CA USA

13. Department of Psychiatry and Behavioral Sciences; Institute of Genetic Medicine, Johns Hopkins University School of Medicine; Baltimore MD USA

Funder

National Institutes of Health/National Institute on Aging

NIA

Eli Lilly

Merck

Novartis

Roche

Biogen

UCSD

Brain Canada

Brain and Behavior Research Foundation

BrightFocus Foundation

Canada Foundation for Innovation

Canada Research Chair

Canadian Institutes of Health Research

Centre for Aging and Brain Health Innovation

National Institutes of Health

Ontario Ministry of Health and Long-Term Care

Ontario Ministry of Research and Innovation

Weston Brain Institute

Canadian Consortium for Neurodegeneration and Aging

Lilly

Alzheimer's Association

NIMH

Associated Jewish Federation of Baltimore

Weinberg Foundation

Forest

GlaxoSmithKline

Eisai

Pfizer

Astra-Zeneca

Ortho-McNeil

Bristol-Myers

National Football League

Elan

Functional Neuromodulation

AstraZeneca

Avanir

Janssen

Genentech

Transition Therapeutics

Toyama

DOD

National Institute on Aging

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3